We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Verseon is a clinical stage company that uses a computer-driven drug discovery platform to design, atom by atom, new drug candidates that are unlikely to be found by conventional methods. Our current drug programs include precision oral anticoagulants, oral drugs for diabetic macular edema and hereditary angioedema, and next-generation chemotherapy agents.
As part of our mission to develop disruptive technologies and products that advance global health, we are rethinking how drug development is funded. Security token offerings (STOs) provide a new, attractive way for companies to raise money and share their successes with a global investor community. However, the major obstacle to widespread adoption of securities transactions n the blockchain has been the enforcement of regulations of all countries involved. Through our subsidiary BlockRules Ltd., we are building the key missing piece of technology that allows the transition of securities issuance and trading on the blockchain.